Investors Actively Trade These 4 Healthcare Stocks Post Earnings

Gilead Sciences Inc. (NASDAQ:GILD) in the first quarter as profit dropped from a year earlier. Net income for the medical-bioengineering fell to $442 million (57 cents per share) vs. $651.1 million (80 cents per share) a year earlier. This is a decline of 32.1% from the year-earlier quarter. Revenue rose 18.5% to $2.28 billion from the year-earlier quarter. Gilead Sciences Inc. reported adjusted net income of 91 cents per share. By that measure, the company fell short of mean estimate of 92 cents per share. It beat the average revenue estimate of $2.2 billion.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported its results for the first quarter. Reported a profit of $91.6 million (43 cents per diluted share) in the quarter. The medical-bioengineering had a net loss of $176.1 million or a loss of 87 cents per share in the year-earlier quarter.Revenue rose more than fivefold to $438.7 million from the year-earlier quarter. Vertex Pharmaceuticals Incorporated reported adjusted net income of 55 cents per share. By that measure, the company fell short of mean estimate of 58 cents per share. It fell short of the average revenue estimate of $456.1 million.

athenahealth Inc. (NASDAQ:ATHN) reported results for the first quarter. Net income for athenahealth, Inc. fell to $2.4 million (7 cents per share) vs. $3.3 million (9 cents per share) a year earlier. This is a decline of 25.3% from the year-earlier quarter.Revenue rose 38.1% to $96.6 million from the year-earlier quarter. athenahealth, Inc. reported adjusted net income of 17 cents per share. By that measure, the company beat the mean estimate of 8 cents per share. It beat the average revenue estimate of $93.6 million.

Cerner Corporation (NASDAQ:CERN) reported net income above Wall Street’s expectations for the first quarter. Net income for Cerner Corporation rose to $88.7 million (52 cents per share) vs. $64.6 million (38 cents per share) in the same quarter a year earlier. This marks a rise of 37.4% from the year-earlier quarter. Revenue rose 30.4% to $641.2 million from the year-earlier quarter. Cerner Corporation reported adjusted net income of 54 cents per share. By that measure, the company beat the mean estimate of 47 cents per share. It beat the average revenue estimate of $578.4 million.